Published in Antimicrob Agents Chemother on March 01, 1976
In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob Agents Chemother (1980) 1.87
Antiviral and antimetabolic activities of neplanocins. Antimicrob Agents Chemother (1985) 1.71
Characterization of an Epstein-Barr virus-induced DNA polymerase. J Virol (1979) 1.36
Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob Agents Chemother (1977) 1.27
In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. Antimicrob Agents Chemother (1982) 1.12
Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis. Antimicrob Agents Chemother (1981) 1.04
Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor. Antimicrob Agents Chemother (1976) 1.01
Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds. Antimicrob Agents Chemother (1984) 0.83
Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro. Antimicrob Agents Chemother (1979) 0.82
Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA. Nucleic Acids Res (1989) 0.80
Synthesis and evaluation of some novel phosphate and phosphinate derivatives of araA. Studies on the mechanism of action of phosphate triesters. Nucleic Acids Res (1989) 0.78
Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med (1953) 3.78
The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med (1958) 2.62
The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). Chemotherapy (1968) 2.28
A NEW MEMBER OF THE HERPESVIRUS GROUP ISOLATED FROM SOUTH AMERICAN MARMOSETS. J Immunol (1964) 2.07
Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis (1974) 1.74
Observations on the growth of varicella-zoster virus in human diploid cells. J Gen Virol (1973) 1.48
Treatment of varicella-zoster virus infections with adenine arabinoside. J Infect Dis (1975) 1.41
Plaque assay for measurement of cells infected with zoster virus. Science (1963) 1.37
Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. Antimicrob Agents Chemother (1974) 1.30
INHIBITION OF VARICELLA VIRUS BY 5-IODO-2'-DEOXYURIDINE. Proc Soc Exp Biol Med (1964) 0.94
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J (1991) 4.08
Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome. Proc Natl Acad Sci U S A (1970) 3.05
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA (1984) 2.20
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol (1997) 2.11
A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother (1992) 2.07
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther (1987) 1.84
Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J (1994) 1.83
The metabolism of ribavirin in erythrocytes and nucleated cells. Int J Biochem (1990) 1.77
Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother (1987) 1.74
Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med (1983) 1.59
Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol (1999) 1.57
Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis (1990) 1.54
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol (1998) 1.53
Plague in San Diego. West J Med (1978) 1.45
The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis (1992) 1.45
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med (1982) 1.42
Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med (1982) 1.41
Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol (1985) 1.40
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol (2001) 1.37
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Generalized type 5 adenovirus infection associated with the pertussis syndrome. J Pediatr (1966) 1.37
Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin. Antimicrob Agents Chemother (1983) 1.35
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis (1989) 1.32
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Evidence for an etiologic role of adenoviral infection in pertussis syndrome. N Engl J Med (1970) 1.30
Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. Antimicrob Agents Chemother (1974) 1.30
Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor. Antimicrob Agents Chemother (1974) 1.28
Disposition of intravenous radioactive acyclovir. Clin Pharmacol Ther (1981) 1.27
Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob Agents Chemother (1977) 1.27
Adenovirus type 7b in a children's hospital. J Infect Dis (1983) 1.26
Extraintestinal manifestations of shigellosis. Am J Gastroenterol (1970) 1.25
Single-dose pharmacokinetics of acyclovir. Antimicrob Agents Chemother (1981) 1.23
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22
The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol (2001) 1.21
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Antimicrob Agents Chemother (1982) 1.20
Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis (1998) 1.19
Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery (1980) 1.19
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. Pediatr Infect Dis J (2001) 1.18
Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther (1978) 1.16
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics (1983) 1.16
Infectious diarrheas. Pediatr Clin North Am (1967) 1.14
A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis (1980) 1.13
The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis (1984) 1.13
Caudate nucleus neurones: correlation of the effects of substantia nigra stimulaton with iontophoretic dopamine. J Physiol (1970) 1.12
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther (1987) 1.10
Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis (1982) 1.09
Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J (2001) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
A central effect of angiotensin: release of pituitary pressor material. J Pharmacol Exp Ther (1970) 1.08
Intracellularly-recorded effects of glutamate and aspartate on neurones in the guinea-pig olfactory cortex slice. Brain Res (1980) 1.08
Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group. J Infect Dis (1995) 1.06
T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol (1994) 1.05
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol (1991) 1.05
High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay. Antimicrob Agents Chemother (1989) 1.04
Relapse of Hemophilus influenzae type b meningitis during intravenous therapy with ampicillin. J Pediatr (1969) 1.04
Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection. AIDS Res Hum Retroviruses (1993) 1.04
Bordetella pertussis serotypes in a whooping cough outbreak. Am J Epidemiol (1974) 1.03
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. Ann Intern Med (1990) 1.03
Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med (1993) 1.02
Diagnosis of HIV infection in children. Pediatr Clin North Am (2000) 1.02
Cellular (T cell) immunity in the human newborn. Pediatrics (1979) 1.01
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology (1993) 0.98
Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 0.97
High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr (1979) 0.97
Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection. Arch Pathol Lab Med (1982) 0.96
Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis (1993) 0.96
Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr (1987) 0.95
Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol (1985) 0.95
Zinc in maturing rat brain: hippocampal concentration and localization. J Neurochem (1972) 0.95
Neonatal acyclovir pharmacokinetics in patients with herpes virus infections. Am J Med (1982) 0.95
Simple high-performance liquid chromatography method for the simultaneous determination of serum caffeine and paraxanthine following rapid sample preparation. J Chromatogr B Biomed Sci Appl (1998) 0.95
Analysis of the tremor induced by injection of cholinergic agents into the caudate nucleus. Int J Neuropharmacol (1966) 0.94
Linkage relationships of X-linked enzymes glucose-6-phosphate dehydrogenase and hypoxanthine guanine phosphoribosyltransferase: recombination in female offspring of compound heterozygotes. Am J Hum Genet (1974) 0.93
Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy. J Infect Dis (2000) 0.93
Differentiation and characterization of enteroviruses by computer-assisted viral protein fingerprinting. J Clin Microbiol (1998) 0.93
Brain iron: location and function. Prog Food Nutr Sci (1993) 0.93
Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team. Pediatr Infect Dis J (1996) 0.93
Lymphokine production by human milk lymphocytes. Infect Immun (1981) 0.92
Central nervous system tuberculosis in children: a review of 30 cases. Pediatr Infect Dis J (1990) 0.92
Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis. Am J Med (1982) 0.92
Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr (1982) 0.92
Permeability changes in the blood-brain barrier: causes and consequences. CRC Crit Rev Toxicol (1975) 0.92